Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma
Conditions : Nasopharyngeal Carcinoma (NPC) Interventions : Drug: Toripalimab combined with Nimotuzumab; Drug: Nimotuzumab Sponsors : Sun Yat-sen University; Sun Yat-Sen Memorial Hospital of Sun…
Read the full article2d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Qualitative Study Protocol on Ethical Perceptions of Simulative Technologies in Long-Term Dementia Care
doi.org·20m agoAI predicts late breast cancer recurrence risk
yesilscience.com·48m ago
AI Medicare Denials Are Here to Stay
yesilscience.com·4h ago
A blind woman reached out and touched a tree she couldn’t see. She’d ‘heard’ it standing there.
Upworthy·6h ago
Leafy Greens May Cut COPD Risk by 16%, Large UK Study Finds
Science Sensei·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.